Dr. Cameron Howard Lee Named 2019 Helen Hay Whitney Fellow

Dr. Cameron Howard Lee, a postdoctoral fellow in the laboratory of Dr. Sue Biggins at Fred Hutchinson Cancer Research Center, has been named a 2019 Helen Hay Whitney fellow by the Helen Hay Whitney Foundation. The foundation provides independent postdoctoral research support to young biomedical scientists. Lee will use the three-year, $180,000 fellowship to investigate the potential relationship between protein production machinery and…
Read More
Launching a clinical trial is a lot like leaping from an airplane, says Colette Chaney: “You’re scared, you’re exhilarated and you’re hoping for a positive outcome.” The longtime clinical research nurse would know. She’s stood in front of an open door on a plane, steeling herself to skydive. And she’s infused patients with revved-up T cells that had never before…
Read More

Dr. Sita Kugel Named 2018 V Scholar

Fred Hutchinson Cancer Research Center pancreatic cancer researcher Dr. Sita Kugel has been named a 2018 V Scholar by the V Foundation for Cancer Research. The two-year, $200,000 award will support Kugel’s goal of developing a targeted therapy for an aggressive subtype of pancreatic cancer. “I am incredibly humbled and honored to receive this recognition from the V Foundation,” said Kugel, an assistant…
Read More
Fred Hutchinson Cancer Research Center’s Alex Salter was listed on Tuesday as a Forbes “30 Under 30,” an annual who’s-who of influencers under age 30 in the U.S. and Canada. The M.D./Ph.D. student in the lab of Dr. Stan Riddell at Fred Hutch made the list of 30 standouts in the health care category. The magazine says that the honorees in 20 categories represent “a…
Read More

Two New Grants to Fuel Metastatic Breast Cancer Research

Two early-career investigators at Fred Hutchinson Cancer Researcher Center have received grants that will fuel their research into metastatic breast cancer. Dr. Erica Goddard, a postdoctoral research fellow in Dr. Cyrus Ghajar’s Laboratory for the Study of Metastatic Microenvironments, won a Breakthrough Fellowship Award from the Department of Defense Breast Cancer Research Program. She will receive a total of $528,000 over three…
Read More
Eight researchers in the Fred Hutchinson/University of Washington Cancer Consortium have received grants totaling nearly $2 million from the Breast Cancer Research Foundation, or BCRF, funding that will continue to fuel their research through 2019. Most of the grants will go toward new therapies for patients with metastatic cancers. The grants were part of a record-breaking $63 million given out this…
Read More
The Moritz Lab has received research funding totaling nearly $525,000 from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health to develop “novel peptide based biomarkers for Lyme disease diagnostics.” The Moritz group has been at the forefront of the development of whole proteome assay repositories and will apply this technology to Borrelia burgdorferi, the causative…
Read More
Dr. Fuki Hisama, professor (Medical Genetics) was recently awarded the Minority Faculty Mentoring Award from the UW School of Medicine Committee for Minority Faculty Advancement (CMFA). This award recognizes the need for excellence in mentoring of under-represented faculty groups to achieve diversity and inclusion, key elements that can unleash creativity and innovation so that we can meet the health care needs…
Read More
Dr. William Banks, professor (Gerontology and Geriatric Medicine) and associate chief of staff for Research and Development at VA Puget Sound Health Care System has received the 2018 William S. Middleton Award. It is the highest honor conferred by the VA Biomedical Laboratory Research and Development Service. The award recognizes Bank’s long history of contributions to VA research, particularly his…
Read More
It’s notable that the newest class of Allen Distinguished Investigators, announced today by the Paul G. Allen Frontiers Group, includes researchers who are developing new treatments for lymphoma. Lymphoma is the type of blood cancer that led to the death of Microsoft co-founder Paul Allen, the namesake and funder of the research program. The decision to focus on that disease — along with…
Read More